Estimating the price at which hepatitis C treatment with direct-acting antivirals would be cost-saving in Japan.

Scientific Reports
Yueran ZhuoJagpreet Chhatwal

Abstract

In Japan, 1.5-2 million people are chronically infected with hepatitis C virus (HCV) infection. New direct-acting antiviral agents (DAA) offer an unprecedented opportunity to cure HCV. While the price of HCV treatment decreased recently in most countries, it remains one of the highest in Japan. Our objective was to evaluate the cost-effectiveness of HCV treatment in patients of different age groups and to estimate the price at which DAAs become cost-saving in Japan. A previously developed microsimulation model was adapted to the Japanese population and updated with Japan-specific health utilities and costs. Our model showed that compared with no treatment, the incremental cost-effectiveness ratio (ICER) of DAAs at a price USD 41,046 per treatment was USD 9,080 per quality-adjusted life year (QALY) gained in 60-year-old patients. HCV treatment became cost-effective after 9 years of starting treatment. However, if the price of DAAs is reduced by 55-85% (USD 6,730 to 17,720), HCV treatment would be cost-saving within a 5 to 20-year time horizon, which should serve to increase the uptake of DAA-based HCV treatment. The payers of health care in Japan could examine ways to procure DAAs at a price where they would be cost-saving.

References

Jan 1, 1994·Intervirology·H Okamoto, S Mishiro
Aug 1, 1996·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P Bedossa, T Poynard
Mar 26, 2003·The American Journal of Gastroenterology·Christopher A K Y ChongMurray Krahn
Jul 21, 2006·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Janel HanmerDennis G Fryback
Jul 10, 2007·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Iwao IkaiMasatoshi Kudo
Jun 20, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hla-Hla TheinMurray D Krahn
Jan 14, 2010·Intervirology·Hobyung ChungMasatoshi Kudo
Apr 28, 2010·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·R A WolfeR M Merion
Jul 16, 2010·Journal of Clinical Gastroenterology·Keith L DavisVinod Rustgi
Sep 18, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jagpreet ChhatwalElamin H Elbasha
Apr 15, 2014·The New England Journal of Medicine·Nezam AfdhalUNKNOWN ION-1 Investigators
Jan 24, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David R NelsonUNKNOWN ALLY-3 Study Team
Jun 26, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·UNKNOWN AASLD/IDSA HCV Guidance Panel
Oct 7, 2015·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Phil McEwanHiromitsu Kumada
Nov 7, 2015·European Journal of Gastroenterology & Hepatology·Phil McEwanMichael Brenner
Sep 9, 2016·Current Medical Research and Opinion·Ataru IgarashiKiichiro Tsutani
Sep 10, 2016·Current Medical Research and Opinion·Ataru IgarashiMichael Lopresti
Apr 14, 2017·The Lancet. Gastroenterology & Hepatology·UNKNOWN Polaris Observatory HCV Collaborators
Jan 10, 2018·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Terumi KaishimaJunko Tanaka
Jan 30, 2018·Alimentary Pharmacology & Therapeutics·J ChhatwalS C Gordon
Nov 2, 2018·JAMA : the Journal of the American Medical Association·Mark R TrusheimPeter B Bach
May 11, 2019·JAMA Network Open·Jagpreet ChhatwalFasiha Kanwal
Jan 19, 2020·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Masataka HasegawaTakashi Fukuda

❮ Previous
Next ❯

Citations

Apr 2, 2020·International Journal of Molecular Sciences·Michael Niepmann, Gesche K Gerresheim
Jul 22, 2021·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Takeshi TerashimaShuichi Kaneko

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Software Mentioned

AuthGrp
MATCH

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Emily D BetheaJagpreet Chhatwal
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
Jagpreet ChhatwalMaria A Lopez-Olivo
Przegla̧d epidemiologiczny
Anna Szymanek, Simon Krzysztof
© 2021 Meta ULC. All rights reserved